Drug Approval | June 07, 2024
Indoco Remedies receives tentative ANDA approval for Canagliflozin, Metformin Hydrochloride Tablets
Canagliflozin and Metformin Hydrochloride Tablets are used to treat type 2 diabetes mellitus
Canagliflozin and Metformin Hydrochloride Tablets are used to treat type 2 diabetes mellitus
mRESVIA is Moderna's second approved product and the only RSV vaccine available in single-dose pre-filled syringes
Acceptance based on results demonstrated a statistically significant improvement in overall survival versus chemotherapy alone in these patients
This marks the first FDA approval of an AI-based brain disorder analysis solution from Korea
_256_384.jpg)
Cipla's Lanreotide Injection is AP-rated therapeutic equivalent generic version of Somatuline Depot (Lanreotide) Injection
The approval of YESAFILI marks Biocon Biologics’ expansion into the ophthalmology therapeutic area in the United States
U.S. FDA has informed Moderna that due to administrative constraints, the agency will not complete its review of mRNA-1345 by the PDUFA date of May 12, 2024
Lupin updates on shipment of Mirabegron ER Tablets
The product is used to treat amyotrophic lateral sclerosis
Eugia Pharma Specialities receives 7 observations from USFDA for Unit II
Subscribe To Our Newsletter & Stay Updated
